AstraZeneca breathes sigh of relief as court blocks US Symbicort genericA US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing Share XAstraZeneca breathes sigh of relief as court blocks US Symbicort generichttps://pharmaphorum.com/news/astrazeneca-breathes-sigh-of-relief-as-court-blocks-us-symbicort-generic/
FDA clears third emergency COVID-19 vaccine from J&JThe FDA has approved emergency use of a third COVID-19 vaccine from Johnson & Johnson’s Janssen Biotech unit, Share XFDA clears third emergency COVID-19 vaccine from J&Jhttps://pharmaphorum.com/news/fda-clears-third-emergency-covid-19-vaccine-from-jj/
NICE okays regular NHS funding for Novartis’ breast cancer drug KisqaliNICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously Share XNICE okays regular NHS funding for Novartis’ breast cancer drug Kisqalihttps://pharmaphorum.com/news/nice-okays-regular-nhs-funding-for-novartis-breast-cancer-drug-kisqali/
COVAX vaccine-sharing scheme delivers first COVID shots to GhanaThe first deliveries of vaccines from the World Health Organization-backed COVAX initiative, which aims to ensure access in Share XCOVAX vaccine-sharing scheme delivers first COVID shots to Ghanahttps://pharmaphorum.com/news/on-mission-to-provide-access-in-poorer-countries-covax-delivers-first-covid-vaccines/
FDA reviewer backs J&J COVID jab for emergency OKJohnson & Johnson’s one-shot coronavirus vaccine is due to be reviewed by an FDA advisory committee on Friday, Share XFDA reviewer backs J&J COVID jab for emergency OKhttps://pharmaphorum.com/news/fda-reviewer-backs-jj-covid-jab-for-emergency-ok/
AZ to divert COVID-19 vaccines from global supply chain to meet EU targetAstraZeneca has said it will be able to meet a target to deliver 180 million COVID-19 vaccines to Share XAZ to divert COVID-19 vaccines from global supply chain to meet EU targethttps://pharmaphorum.com/news/az-to-miss-q2-covid-19-vaccine/
AZ withdraws Imfinzi in US bladder cancer use after trial failureAstraZeneca has suffered a setback after it voluntarily withdrew its cancer immunotherapy Imfinzi (durvalumab) in a bladder cancer Share XAZ withdraws Imfinzi in US bladder cancer use after trial failurehttps://pharmaphorum.com/news/az-withdraws-imfinzi-in-us-bladder-cancer-use-after-trial-setback/
Novavax provides 1.1 billion COVID shots to global vaccine driveNovavax has signed a deal to provide 1.1 billion doses of its COVID-19 vaccine to the COVAX global Share XNovavax provides 1.1 billion COVID shots to global vaccine drivehttps://pharmaphorum.com/news/novavax-provides-1-1-billion-covid-shots-to-global-vaccine-drive/
Europe orders another 200m doses of Pfizer/BioNTech COVID shotThe European Commission has ordered another 200 million doses of the Pfizer/BioNTech COVID-19 vaccine Comirnaty, bringing the bloc’s Share XEurope orders another 200m doses of Pfizer/BioNTech COVID shothttps://pharmaphorum.com/news/europe-orders-another-200m-doses-of-pfizer-biontech-covid-shot/
